Relationship between pulmonary matrix metalloproteinases and quantitative CT markers of small airways disease and emphysema in COPD-Reference-Cited by-同舟云学术

Relationship between pulmonary matrix metalloproteinases and quantitative CT markers of small airways disease and emphysema in COPD

Published:2015-12-08 Issue:2 Volume:71 Page:126-132
ISSN:0040-6376
Container-title:Thorax
language:en
Short-container-title:Thorax

Author:

Ostridge Kristoffer^ORCID,Williams Nicholas,Kim Viktoriya,Bennett Michael,Harden Stephen,Welch Lindsay,Bourne Simon,Coombs Ngaire A,Elkington Paul T,Staples Karl J,Wilkinson Tom MA

Publisher

BMJ

Subject

Pulmonary and Respiratory Medicine

Reference37 articles.

1. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary;Rabe;Am J Respir Crit Care Med,2007

2. Emerging pharmacotherapies for COPD;Barnes;Chest,2008

3. Pathogenic triad in COPD: oxidative stress, protease-antiprotease imbalance, and inflammation;Fischer;Int J Chron Obstruct Pulmon Dis,2011

4. Series ‘matrix metalloproteinases in lung health and disease’: matrix metalloproteinases in COPD;Churg;Eur Respir J,2012

5. Matrix metalloproteinases in destructive pulmonary pathology;Elkington;Thorax,2006

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small airways disease in chronic obstructive pulmonary disease;Expert Review of Respiratory Medicine;2024-07-02

2. Exploratory Study on COPD Phenotypes and their Progression: Integrating SPECT and qCT Imaging Analysis;2024-04-13

3. The future drug treatment of COPD;COPD in the 21st Century;2024-03-01

4. The Molecular Blueprint for Chronic Obstructive Pulmonary Disease (COPD): A New Paradigm for Diagnosis and Therapeutics;Oxidative Medicine and Cellular Longevity;2023-12-21

5. A Macrophage-Related Gene Signature for Identifying COPD Based on Bioinformatics and ex vivo Experiments;Journal of Inflammation Research;2023-11